188 related articles for article (PubMed ID: 4843169)
1. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
Tseng LF; Hitzemann RJ; Loh HH
J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
[No Abstract] [Full Text] [Related]
2. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
Heikkila RE; Orlansky H; Mytilineou C; Cohen G
J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
[TBL] [Abstract][Full Text] [Related]
3. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
Arnold EB; Molinoff PB; Rutledge CO
J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
[No Abstract] [Full Text] [Related]
4. Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain.
Taylor KM; Snyder SH
Brain Res; 1971 May; 28(2):295-309. PubMed ID: 5113521
[No Abstract] [Full Text] [Related]
5. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
Wenger GR; Rutledge CO
J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
[No Abstract] [Full Text] [Related]
6. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Thornburg JE; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
[No Abstract] [Full Text] [Related]
7. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
[No Abstract] [Full Text] [Related]
8. Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.
Horn AS; Coyle JT; Snyder SH
Mol Pharmacol; 1971 Jan; 7(1):66-80. PubMed ID: 5552252
[No Abstract] [Full Text] [Related]
9. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
Holmes JC; Rutledge CO
Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
[No Abstract] [Full Text] [Related]
10. Morphine effects on the levels and turnover of catecholamines in rat brain.
Johnson JC; Ratner M; Gold CJ; Clouet DH
Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
[No Abstract] [Full Text] [Related]
11. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
Feigenbaum J; Yanai J; Klawans H; Moon B
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
[TBL] [Abstract][Full Text] [Related]
12. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
Baldessarini RJ; Harris JE
J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
[No Abstract] [Full Text] [Related]
13. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
Harris JE; Baldessarini RJ
Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
[No Abstract] [Full Text] [Related]
14. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
Ferris RM; Tang FL; Maxwell RA
J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
[No Abstract] [Full Text] [Related]
15. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
Feigenbaum JJ; Yanai J; Blass RB
Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
[TBL] [Abstract][Full Text] [Related]
16. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
Azzaro AJ; Ziance RJ; Rutledge CO
J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
[No Abstract] [Full Text] [Related]
17. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
Horn AS; Snyder SH
J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
[No Abstract] [Full Text] [Related]
18. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
Tseng LF; Loh HH
J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
[No Abstract] [Full Text] [Related]
19. Compartmentation of dopamine in rat striatum.
Doteuchi M; Wang C; Costa E
Mol Pharmacol; 1974 Mar; 10(2):225-34. PubMed ID: 4152816
[No Abstract] [Full Text] [Related]
20. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
Azzaro AJ; Rutledge CO
Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
